...
首页> 外文期刊>Journal of atherosclerosis and thrombosis. >Persistent Dysfunction of Coronary Endothelial Vasomotor Responses is Related to Atheroma Plaque Progression in the Infarct-Related Coronary Artery of AMI Survivors
【24h】

Persistent Dysfunction of Coronary Endothelial Vasomotor Responses is Related to Atheroma Plaque Progression in the Infarct-Related Coronary Artery of AMI Survivors

机译:急性心肌梗死相关冠状动脉粥样硬化斑块进展与冠状动脉内皮血管舒缩功能持续障碍有关。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Aim: Although coronary endothelial vasomotor dysfunction predicts future coronary events, there are few human studies showing the relationship between endothelial vasomotor dysfunction and atheroma plaque progression in the same coronary artery. This study examined whether endothelial vasomotor dysfunction is related to atheroma plaque progression in the infarct-related coronary artery of ST-segment elevation myocardial infarction (STEMI) survivors using serial assessment of coronary plaque size with intravascular ultrasound (IVUS) and coronary vasomotor responses to acetylcholine (ACh). Methods: This study included 50 patients with a first acute STEMI due to occlusion of the left anterior descending coronary artery (LAD) and successful reperfusion therapy with percutaneous coronary intervention (PCI). IVUS and vasomotor response to ACh in the LAD were measured within two weeks of acute myocardial infarction (AMI) (1supst/sup test) and repeated six months (2supnd/sup test) after AMI under optimal anti-atherosclerotic therapies. Results: Percent atheroma volume (PAV) and total atheroma volume (TAV) in the LAD progressed over six months of follow-up in 18 and 14 patients, respectively. PAV and TAV progression was significantly associated with persistent impairment of epicardial coronary artery dilation and coronary blood flow increase in response to ACh at both the 1supst/sup and 2supnd/sup tests. PAV and TAV progression had no significant association with traditional risk factors, PCI-related variables, medications, and the coronary vasomotor responses to sodium nitroprusside, an endothelium-independent vasodilator. Conclusions: Persistent impairment of endothelial vasomotor function in the conduit arterial segment and the resistance arteriole was related to atheromatous plaque progression in the infarct-related coronary arteries of STEMI survivors.
机译:目的:尽管冠状动脉内皮血管舒缩功能障碍预示着未来的冠状动脉事件,但很少有人类研究表明同一冠状动脉中的内皮血管舒缩功能障碍与动脉粥样斑块进展之间的关系。本研究使用血管内超声(IVUS)对冠状斑块大小的连续评估以及冠状动脉对乙酰胆碱的血管舒缩反应评估了ST段抬高型心肌梗死(STEMI)幸存者的梗死相关冠状动脉粥样斑块进展是否与内皮血管舒缩功能障碍有关(ACh)。方法:该研究纳入了50例因阻塞左前降支冠状动脉(LAD)而首次急性STEMI并经皮冠状动脉介入治疗(PCI)成功进行再灌注治疗的患者。在急性心肌梗死(AMI)(1 st 测试)两周内和重复六个月(2 nd 测试)后,对LAD中的IVUS和对ACh的血管舒缩反应进行了测量最佳抗动脉粥样硬化疗法下的AMI。结果:LAD的动脉粥样硬化体积百分比(PAV)和总动脉粥样硬化体积(TAV)在六个月的随访中分别进展为18和14例患者。 PAV和TAV的进展与心外膜冠状动脉扩张的持续障碍和在1 和2 测试中对ACh的冠状动脉血流量增加显着相关。 PAV和TAV的进展与传统危险因素,PCI相关变量,药物以及对硝普钠(一种非内皮依赖性血管舒张剂)的冠状血管舒缩反应无显着相关性。结论:STEMI幸存者与梗死相关的冠状动脉粥样斑块进展与导管动脉段内皮血管舒缩功能的持续损伤和抵抗小动脉的进展有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号